Tevogen Highlights Significant Liability Reduction and Continued Insider Control
Tevogen highlights lower liabilities, a 17% year-over-year reduction in nine-month operating loss and continued insider control.
Tevogen highlights lower liabilities, a 17% year-over-year reduction in nine-month operating loss and continued insider control.